Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MORAb-202 |
Trade Name | |
Synonyms | MORAb 202|MORAb202 |
Drug Descriptions |
MORAb-202 is an anti-folate receptor alpha (FRA) antibody (farletuzumab) in conjugation with eribulin, which may lead to cytotoxic killing of FRA-positive tumors (Mol Cancer Ther 2018;17(1 Suppl):Abstract nr B115, PMID: 30262588). |
DrugClasses | FOLR1-targeted Therapy 24 |
CAS Registry Number | NA |
NCIT ID | C173946 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MORAb-202 | MORAb-202 | 0 | 3 |